| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
71,433 |
48,121 |
$365K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
119,465 |
77,888 |
$348K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,868 |
3,281 |
$255K |
| 84443 |
Thyroid stimulating hormone (TSH) |
22,669 |
20,386 |
$182K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
43,523 |
28,994 |
$181K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,356 |
3,774 |
$130K |
| 84484 |
|
18,453 |
13,038 |
$105K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,193 |
3,785 |
$88K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13,717 |
11,980 |
$87K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,045 |
2,612 |
$85K |
| 83874 |
|
9,177 |
7,299 |
$85K |
| 83735 |
|
24,490 |
9,417 |
$83K |
| 87040 |
|
6,285 |
4,665 |
$74K |
| 82948 |
|
32,620 |
11,131 |
$72K |
| 80061 |
Lipid panel |
22,836 |
20,142 |
$69K |
| 82805 |
|
5,402 |
2,872 |
$67K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,525 |
2,175 |
$64K |
| 87088 |
|
10,237 |
9,160 |
$56K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
17,633 |
15,721 |
$55K |
| 87631 |
|
1,083 |
1,044 |
$52K |
| 83690 |
|
13,250 |
11,490 |
$45K |
| 83880 |
|
4,307 |
3,308 |
$42K |
| 84703 |
|
11,735 |
10,398 |
$41K |
| 81001 |
|
28,278 |
24,882 |
$41K |
| 83605 |
|
7,508 |
4,892 |
$39K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,673 |
4,261 |
$36K |
| 87400 |
|
5,559 |
5,021 |
$35K |
| 84439 |
|
7,900 |
7,188 |
$34K |
| 88307 |
|
511 |
426 |
$33K |
| 80306 |
|
5,487 |
4,735 |
$32K |
| 86850 |
|
10,822 |
9,124 |
$31K |
| 86901 |
|
13,824 |
11,805 |
$31K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,373 |
1,331 |
$30K |
| 84702 |
|
6,371 |
5,282 |
$30K |
| 84100 |
|
16,357 |
6,023 |
$29K |
| 85027 |
|
9,053 |
5,127 |
$26K |
| 86900 |
|
13,814 |
11,792 |
$23K |
| 83970 |
|
1,477 |
1,297 |
$23K |
| 82728 |
|
5,674 |
4,090 |
$21K |
| 82803 |
|
2,316 |
1,119 |
$21K |
| 87653 |
|
970 |
936 |
$21K |
| 84145 |
|
1,573 |
643 |
$21K |
| 85730 |
|
6,701 |
5,123 |
$21K |
| 85379 |
|
5,416 |
3,062 |
$20K |
| 85610 |
|
10,139 |
7,121 |
$20K |
| 87186 |
|
2,976 |
2,624 |
$19K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
425 |
309 |
$19K |
| 82570 |
|
7,653 |
6,518 |
$18K |
| 82607 |
|
2,926 |
2,637 |
$17K |
| 87081 |
|
5,907 |
5,451 |
$17K |
| 84466 |
|
3,972 |
3,555 |
$17K |
| 86803 |
|
1,997 |
1,809 |
$16K |
| 88342 |
|
1,122 |
900 |
$15K |
| 83540 |
|
4,639 |
4,154 |
$15K |
| 86328 |
|
319 |
245 |
$14K |
| 86140 |
|
5,485 |
3,429 |
$13K |
| 87340 |
|
1,983 |
1,811 |
$12K |
| 80074 |
|
651 |
576 |
$12K |
| 80202 |
|
1,604 |
758 |
$11K |
| 86756 |
|
1,245 |
1,166 |
$10K |
| 80076 |
|
3,214 |
2,811 |
$10K |
| 87486 |
|
427 |
310 |
$10K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
427 |
309 |
$9K |
| 82550 |
|
4,534 |
2,097 |
$9K |
| 82746 |
|
1,522 |
1,368 |
$9K |
| 82247 |
|
4,488 |
2,292 |
$8K |
| 84481 |
|
1,701 |
1,573 |
$8K |
| 83615 |
|
4,128 |
2,021 |
$8K |
| 87070 |
|
2,308 |
2,072 |
$8K |
| 88304 |
|
383 |
346 |
$7K |
| 87185 |
|
1,657 |
1,340 |
$7K |
| 85520 |
|
1,872 |
499 |
$7K |
| 84153 |
|
1,126 |
1,068 |
$7K |
| 82043 |
|
3,450 |
3,065 |
$7K |
| 84480 |
|
1,452 |
1,287 |
$7K |
| 85651 |
|
2,866 |
2,533 |
$7K |
| 87581 |
|
429 |
309 |
$6K |
| 86592 |
|
3,108 |
2,767 |
$6K |
| 81003 |
|
5,375 |
4,947 |
$6K |
| 87205 |
|
3,008 |
2,370 |
$6K |
| 83001 |
|
655 |
564 |
$6K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
636 |
482 |
$5K |
| 85018 |
|
4,299 |
3,694 |
$5K |
| 86706 |
|
689 |
649 |
$5K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
362 |
359 |
$5K |
| 84156 |
|
3,827 |
3,149 |
$4K |
| 85014 |
|
3,721 |
3,126 |
$4K |
| 82248 |
|
3,272 |
2,454 |
$4K |
| 84146 |
|
590 |
526 |
$4K |
| 86880 |
|
1,559 |
1,446 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
121 |
114 |
$4K |
| 80055 |
|
192 |
183 |
$3K |
| 86431 |
|
754 |
692 |
$3K |
| 82565 |
|
1,124 |
1,065 |
$3K |
| 86762 |
|
640 |
569 |
$3K |
| 80069 |
|
597 |
410 |
$3K |
| 84550 |
|
1,392 |
1,243 |
$3K |
| 82950 |
|
1,093 |
997 |
$2K |
| 87493 |
|
106 |
95 |
$2K |
| 82436 |
|
1,024 |
845 |
$2K |
| 84300 |
|
1,113 |
907 |
$2K |
| 82784 |
|
183 |
158 |
$2K |
| 84133 |
|
1,025 |
851 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
91 |
63 |
$2K |
| 84520 |
|
1,307 |
1,230 |
$2K |
| 81025 |
|
713 |
671 |
$2K |
| 82010 |
|
962 |
812 |
$2K |
| 83002 |
|
327 |
266 |
$2K |
| 80164 |
|
384 |
301 |
$2K |
| 85384 |
|
533 |
387 |
$2K |
| 84436 |
|
396 |
377 |
$1K |
| 85007 |
|
719 |
396 |
$1K |
| 87210 |
|
483 |
449 |
$1K |
| 86593 |
|
570 |
553 |
$1K |
| 88720 |
|
523 |
443 |
$1K |
| 82140 |
|
271 |
173 |
$1K |
| 85045 |
|
805 |
681 |
$933.56 |
| 83013 |
|
49 |
42 |
$791.87 |
| 82951 |
|
103 |
103 |
$647.54 |
| 88302 |
|
29 |
26 |
$493.57 |
| 88141 |
|
58 |
55 |
$456.96 |
| 86077 |
|
13 |
12 |
$449.88 |
| 82378 |
|
57 |
53 |
$382.47 |
| 88341 |
|
15 |
14 |
$378.06 |
| 88112 |
|
15 |
15 |
$258.40 |
| 83014 |
|
61 |
54 |
$233.63 |
| 83009 |
|
12 |
12 |
$227.49 |
| 82670 |
|
25 |
25 |
$217.88 |
| 82952 |
|
103 |
102 |
$198.19 |
| 82330 |
|
22 |
12 |
$187.04 |
| 87075 |
|
30 |
25 |
$186.51 |
| 82533 |
|
16 |
14 |
$111.90 |
| 86704 |
|
13 |
12 |
$102.05 |
| 80178 |
|
31 |
27 |
$100.13 |
| 87045 |
|
14 |
12 |
$67.65 |
| 83525 |
|
15 |
12 |
$64.41 |
| 84165 |
|
12 |
12 |
$63.99 |
| 82150 |
|
14 |
12 |
$44.66 |
| 83935 |
|
15 |
14 |
$37.28 |
| 87046 |
|
14 |
12 |
$13.20 |
| 86923 |
|
76 |
58 |
$9.50 |
| 87071 |
|
49 |
45 |
$0.00 |
| G0431 |
Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter |
649 |
486 |
$0.00 |